Compounds and methods for treating tight junction permeabtility
US11608359B2 · kind B2 · utility
0Cited by
27References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 2019 |
| Grant date | Mar 21, 2023 |
| Priority date | — |
| Expiry date | Feb 25, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides Larazotide derivative compositions that resist protease degradation, and in various embodiments, do not demonstrate an inverse dose response, and/or can be delivered at higher doses without loss of potency or efficacy, thereby allowing improved therapy and more desirable dosing schedules.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.